Luxembourg vs Switzerland: Proportion of bloodstream infection due to methicillin-resistant
Luxembourg
4.7%
in 2022
Switzerland
4.0%
in 2023
Luxembourg rank
48th
Switzerland rank
50th
Proportion of bloodstream infection due to methicillin-resistant over time
- Luxembourg
- Switzerland
How they compare
Luxembourg currently reports 4.7% against 4.0% in Switzerland, a difference of 0.7%.
That makes Luxembourg's figure about 1.2 times Switzerland's.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was Luxembourg ahead.
Luxembourg ranks 48th and Switzerland ranks 50th of 55 countries.
Across the 2 decades both report, Luxembourg averaged higher in 1 and Switzerland in 1.
Head to head by decade
| Decade | Luxembourg | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 7.8% | 4.8% | 3.0% | Luxembourg |
| 2020s | 4.4% | 4.5% | 0.1% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of bloodstream infection due to methicillin-resistant, Luxembourg or Switzerland?
- Luxembourg, at 4.7% against 4.0% in Switzerland as of 2022.
- What is the difference in proportion of bloodstream infection due to methicillin-resistant between Luxembourg and Switzerland?
- 0.7%, with Luxembourg ahead.
- How many years of comparable data are there for Luxembourg and Switzerland?
- 6 years are reported by both, from 2017 to 2022.
- How do Luxembourg and Switzerland rank globally for proportion of bloodstream infection due to methicillin-resistant?
- Luxembourg ranks 48th and Switzerland ranks 50th of 55 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.